Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Anterogen Company

Anterogen Company
2000 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
065660 STOCK SYMBOL
$32.63 SHARE PRICE (As of Wednesday Closing)
Description

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • Namsung Plaza, Gasan-dong
  • 405, 130, Digital-ro, Geumcheon-gu
  • Seoul, 153-782
  • South Korea

+82 0000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Anterogen Company’s full profile, request a free trial.

Anterogen Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$24.54 - $93.94 $282M $29.21 -$0.16 88.6K 8.65M

Anterogen Company Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 592,959 519,095 319,928 122,938
Revenue 3,193 3,282 4,724 4,202
EBITDA (145) 538 501 336
Net Income (1,365) (875) 394 319
Total Assets 105,315 90,710 54,404 29,317
Total Debt 26,382 26,372 8,723
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anterogen Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Anterogen Company‘s full profile, request access.

Request full access to PitchBook

Anterogen Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Anterogen Company‘s full profile, request access.

Request full access to PitchBook

Anterogen Company Executive Team (2)

Name Title Board
Seat
Contact
Info
Ike Wan Lee Ph.D Chief Scientific Officer & Founder

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »